Drug Trial Radar · NCT01429441
Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Last checked: Nov 20, 2026Latest source record: Mar 14, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
220
Actual
Start
Oct 2011
Primary completion
Oct 2014
Study completion Oct 2014
Sponsor
- Lead sponsor
- ThromboGenicsIndustry
- Sponsor type
- Industry
- First posted
- Sep 7, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the treatment of symptomatic vitreomacular adhesion / (VMT) including macular hole with ocriplasmin.
Conditions
- Vitreomacular Adhesion Including Macular Hole
Interventions
OcriplasminDrug
0.125 mg single intravitreal injection
Sham injectionOther
Sham injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects With Pharmacological Vitreomacular Adhesion (VMA) / (Vitreomacular Traction [VMT]) Resolution at Day 28Time frame: Day 28
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Retinal Consultants of Arizona
Phoenix, Arizona
Retina-Vitreous Associates Medical Group
Beverly Hills, California
Retina Consultants Medical Group
Sacramento, California
West Coast Retina Group, Inc
San Francisco, California
Bay Area Retina Associates
Walnut Creek, California
MedEye Associates
Miami, Florida
Center for Retina and Macular Disease
Winter Haven, Florida
Associated Retinal Consultants
Royal Oak, Michigan
Sabates Eye Center Research
Kansas City, Missouri
Eyesite Opthalmic Services, PA
Portsmouth, New Hampshire
Retina-Vitreous Center, PA
New Brunswick, New Jersey
Retina Association of NJ
Teaneck, New Jersey
Retina Vitrous Surgeons of CNY
Syracuse, New York
Southeast Clinical Research, PA
Charlotte, North Carolina
Cincinnati Eye Institute
Cincinnati, Ohio
Retina Associates of Cleveland
Cleveland, Ohio
Mid Atlantic Retina
Huntingdon Valley, Pennsylvania
Texas Retina Associates
Arlington, Texas
Retina Research Center
Austin, Texas
Texas Retina Associates
Dallas, Texas
Retina Consultants, PA
Fort Worth, Texas
Vitroretinal Consultants
Houston, Texas
Valley Retina Institute, P.A.
McAllen, Texas
Retina Consultants of San Antonio
San Antonio, Texas
Eye Care Associate
Tyler, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.